Matthew Foy's most recent trade in Decibel Therapeutics Inc was a trade of 7,119,852 Series A Preferred Stock done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 7,119,852 | 0 | - | - | Series A Preferred Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 3,125,000 | 0 | - | - | Series C Preferred Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 1,737,619 | 0 | - | - | Series D Preferred Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 458,487 | 458,487 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 327,852 | 1,033,663 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | 17 Feb 2021 | 247,324 | 705,811 | - | - | Common Stock | ||
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 17 Feb 2021 | 150,000 | 1,183,663 | - | 18 | 2,700,000 | Common Stock |
| Decibel Therapeutics Inc | Matthew Foy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |